Goss Wealth Management »

Bolt Biotherapeutics shares owned by Goss Wealth Management

Quarter-by-quarter ownership of Bolt Biotherapeutics (BOLT) shares owned by Goss Wealth Management from 13F filings

Historical chart of Goss Wealth Management investment in Bolt Biotherapeutics

Tip: Access up to 7 years of quarterly data

All positions including Bolt Biotherapeutics held by Goss Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Bolt Biotherapeutics by Goss Wealth Management

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.7k 2.5k 3.85
2025-06-30 $2.8k 483 5.77

More positions owned by Goss Wealth Management

Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
NVIDIA Corporation (NVDA)
Microsoft Corporation (MSFT)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Series Trust St Str P500etf (SPYM)
Broadcom (AVGO)
Berkshire Hathaway Inc Del Cl B New (BRK.B)
Wal-Mart Stores (WMT)
Blackrock Etf Trust Ishares Us Equit (DYNF)
Cisco Systems (CSCO)

View all positions for Goss Wealth Management

Top funds holding Bolt Biotherapeutics

Sofinnova Ventures
Renaissance Technologies
Vivo Capital
Citadel Advisors
T3 Companies
Board of Trustees of The Leland Stanford Junior University
Pfizer
Lynx1 Capital Management
Nano Cap New Millennium Growth Fund
Geode Capital Management
Shay Capital
BlackRock
Vanguard Capital Management
Nan Fung Group Holdings
Morgan Stanley

View all funds holding Bolt Biotherapeutics